We are live on ! Find out more
NHI icon

National Health Investors

214 hedge funds and large institutions have $2.24B invested in National Health Investors in 2017 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 75 increasing their positions, 72 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 24

4% more funds holding

Funds holding: 206214 (+8)

4% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 72

0.58% less ownership

Funds ownership: 72.05%71.47% (-0.58%)

2% less capital invested

Capital invested by funds: $2.28B → $2.24B (-$46.6M)

76% less call options, than puts

Call options by funds: $2.28M | Put options by funds: $9.29M

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
214
Holders Change
+8
Holders Change %
+3.88%
% of All Funds
4.85%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
33
Increased
75
Reduced
72
Closed
24
Calls
$2.28M
Puts
$9.29M
Net Calls
-$7.02M
Net Calls Change
+$957K
Name Holding Trade Value Shares
Change
Change in
Stake
OAM
101
Oxford Asset Management
United Kingdom
$831K -$882K -11,359 -51%
US Bancorp
102
US Bancorp
Minnesota
$825K +$130K +1,669 +18%
Janney Montgomery Scott
103
Janney Montgomery Scott
Pennsylvania
$796K -$3.26K -42 -0.4%
Citadel Advisors
104
Citadel Advisors
Florida
$773K +$796K +10,252 New
RJFSA
105
Raymond James Financial Services Advisors
Florida
$767K -$150K -1,938 -16%
PI
106
Putnam Investments
Massachusetts
$750K +$21.1K +272 +3%
CIC
107
Cornercap Investment Counsel
Georgia
$700K
HFS
108
HL Financial Services
Kentucky
$690K -$1.55K -20 -0.2%
BNP Paribas Financial Markets
109
BNP Paribas Financial Markets
France
$684K -$583K -7,518 -45%
Bank of Montreal
110
Bank of Montreal
Ontario, Canada
$672K -$543 -7 -0.1%
PAM
111
Panagora Asset Management
Massachusetts
$664K -$5.9K -76 -0.9%
CCM
112
Coldstream Capital Management
Washington
$657K +$35.1K +452 +5%
ADEF
113
Adams Diversified Equity Fund
Maryland
$656K -$194K -2,500 -22%
LF
114
Lee Financial
Texas
$645K -$7.14K -92 -1%
T. Rowe Price Associates
115
T. Rowe Price Associates
Maryland
$618K -$776 -10 -0.1%
FIM
116
Freedom Investment Management
Connecticut
$607K +$54.2K +698 +9%
CEP
117
Chicago Equity Partners
Illinois
$583K -$8.15K -105 -1%
Wolverine Trading
118
Wolverine Trading
Illinois
$582K -$137K -1,762 -19%
CB
119
Commerce Bank
Missouri
$581K -$35.7K -460 -6%
RJA
120
Raymond James & Associates
Florida
$556K +$73.8K +951 +15%
Los Angeles Capital Management
121
Los Angeles Capital Management
California
$546K -$68.1K -878 -11%
Principal Financial Group
122
Principal Financial Group
Iowa
$532K -$1.4K -18 -0.3%
BCM
123
Bridgeway Capital Management
Texas
$524K +$42.7K +550 +9%
FPFS
124
First Personal Financial Services
North Carolina
$519K
Thrivent Financial for Lutherans
125
Thrivent Financial for Lutherans
Minnesota
$514K -$930K -11,980 -64%

NHI Hedge Fund Activity: Q4 2017 in Review

214 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in National Health Investors (NHI) for Q4 2017, worth a combined $2.24B — down 2% from $2.28B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new NHI positions and 24 closed out — a net gain of 9 holders — while 75 added to existing stakes and 72 trimmed.

The largest buyer was Invesco, adding an estimated $22.1M. The largest seller was JP Morgan Chase, cutting an estimated $30.3M.

  • 214 institutional investors held National Health Investors (NHI) as of Q4 2017, up from 206 in Q3 2017.
  • Funds reported $2.24B of National Health Investors stock for Q4 2017, down 2% quarter-over-quarter.
  • 33 funds opened new National Health Investors positions in Q4 2017 and 24 closed out, a net change of +9 holders.
  • The largest National Health Investors buyer in Q4 2017 was Invesco, an estimated $22.1M added.
  • The largest National Health Investors seller in Q4 2017 was JP Morgan Chase, an estimated $30.3M sold.

Based on aggregated 13F filings for Q4 2017.